TN2014000342A1 - New pediatric uses of cabazitaxel - Google Patents

New pediatric uses of cabazitaxel

Info

Publication number
TN2014000342A1
TN2014000342A1 TNP2014000342A TN2014000342A TN2014000342A1 TN 2014000342 A1 TN2014000342 A1 TN 2014000342A1 TN P2014000342 A TNP2014000342 A TN P2014000342A TN 2014000342 A TN2014000342 A TN 2014000342A TN 2014000342 A1 TN2014000342 A1 TN 2014000342A1
Authority
TN
Tunisia
Prior art keywords
cabazitaxel
pediatric uses
new pediatric
new
solvate
Prior art date
Application number
TNP2014000342A
Other languages
French (fr)
Inventor
S Sidhu Sukhvinder
Patricia Vrignaud
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/052518 external-priority patent/WO2013117683A1/en
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of TN2014000342A1 publication Critical patent/TN2014000342A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The present invention relates to the compound of formula (I): which may be in the form of an anhydrous base, a hydrate or a solvate, for its use for the treatment of pediatric cancers.
TNP2014000342A 2012-10-30 2014-08-07 New pediatric uses of cabazitaxel TN2014000342A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306352 2012-10-30
PCT/EP2013/052518 WO2013117683A1 (en) 2012-02-10 2013-02-08 New pediatric uses of cabazitaxel

Publications (1)

Publication Number Publication Date
TN2014000342A1 true TN2014000342A1 (en) 2015-12-21

Family

ID=47137643

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2014000342A TN2014000342A1 (en) 2012-10-30 2014-08-07 New pediatric uses of cabazitaxel

Country Status (1)

Country Link
TN (1) TN2014000342A1 (en)

Similar Documents

Publication Publication Date Title
PH12017502141A1 (en) Compounds and their methods of use
PH12014502169A1 (en) N-cyclylamides as nematicides
NZ700928A (en) Dna-pk inhibitors
IN2014DN09346A (en)
MX2015002040A (en) Deuterated baricitinib.
IN2015DN00598A (en)
MX2015014298A (en) Dihydropyrido pyrimidine compounds as autotaxin inhibitors.
MX2015007097A (en) Novel bi-ring phenyl-pyridines/pyrazines for the treatment of cancer.
MX2014012477A (en) Pyrrolopyrazone inhibitors of tankyrase.
PH12015501088A1 (en) Dimeric compounds
GEP201706690B (en) Novel process for making compounds for use in treatment of cancer
TN2012000469A1 (en) Use of novel pan-cdk inhibitors for treating tumors
GEP201706626B (en) Synthesis of (s)-nifuratel
NZ720106A (en) A process for the preparation of regadenoson
PH12015500399A1 (en) Azaindolines
MX2016001641A (en) Cyclobutyl carboxamides as nematicides.
AU2016204389A1 (en) Kinase inhibitors for the treatment of cancer
MX2015014470A (en) Combretastatin analogs.
MX365192B (en) Bendamustine derivatives and related compounds, and medical use thereof cancer therapy.
MX2016000487A (en) Pyridine-2-carboxamides as nematocides.
EA033160B1 (en) Compounds for the treatment of ischemia-reperfusion- related diseases
PH12015502703A1 (en) Pharmaceutical compositions
PH12014501794A1 (en) New pediatric uses of cabazitaxel
TN2014000342A1 (en) New pediatric uses of cabazitaxel
MX2017014463A (en) Cabazitaxel and its use for treating cancer.